carbamates and cannabidiol

carbamates has been researched along with cannabidiol in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Drysdale, AJ; Pertwee, RG; Platt, B; Ryan, D1
Limebeer, CL; Mechoulam, R; Parker, LA; Piomelli, D; Rock, EM1
Bosier, B; Lambert, DM; Muccioli, GG1
Del-Bel, EA; Gomes, FV; Guimarães, FS; Issy, AC; Pedrazzi, JF1
Chaves, YC; Crippa, JA; da Cunha, JM; de Morais, H; Genaro, K; Jesus, CHA; Waltrick, APF; Zanoveli, JM1
Hussar, DA1
Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS1
Jiang, X; Liu, XH; Shi, J; Tang, W; Wang, S; Wu, C; Xu, Y; Zha, L; Zhang, J; Zhang, Z; Zuo, J1

Other Studies

8 other study(ies) available for carbamates and cannabidiol

ArticleYear
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
    The European journal of neuroscience, 2007, Volume: 25, Issue:7

    Topics: Animals; Arachidonic Acids; Benzamides; Calcium; Cannabidiol; Cannabinoid Receptor Modulators; Carbamates; Cells, Cultured; Dronabinol; Endocannabinoids; Estrenes; Glutamic Acid; Glycerides; Hippocampus; Humans; Morpholines; Pertussis Toxin; Phosphodiesterase Inhibitors; Polyunsaturated Alkamides; Pyrazoles; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Signal Transduction

2007
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat.
    Psychopharmacology, 2008, Volume: 196, Issue:3

    Topics: Amidohydrolases; Animals; Antiemetics; Antineoplastic Agents; Benzamides; Cannabidiol; Carbamates; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Lithium Chloride; Male; Nausea; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Vomiting, Anticipatory

2008
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    British journal of pharmacology, 2013, Volume: 169, Issue:4

    Topics: Amidohydrolases; Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Antidepressive Agents; Benzamides; Cannabidiol; Cannabinoid Receptor Antagonists; Carbamates; Cell Line, Tumor; Corpus Striatum; Dopaminergic Neurons; Endocannabinoids; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Reporter; Hippocampus; Mice; Nerve Tissue Proteins; Peroxisome Proliferator-Activated Receptors; Promoter Regions, Genetic; Receptor, Cannabinoid, CB1; Tyrosine 3-Monooxygenase

2013
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine.
    Psychopharmacology, 2015, Volume: 232, Issue:16

    Topics: Amphetamine; Animals; Benzamides; Cannabidiol; Carbamates; Inhibition, Psychological; Male; Mice; Nucleus Accumbens; Prepulse Inhibition; Reflex, Startle

2015
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
    Neuroscience letters, 2018, 08-24, Volume: 682

    Topics: Animals; Antidepressive Agents; Benzamides; Cannabidiol; Carbamates; Depression; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Swimming

2018
New Drugs 2019, part 3.
    Nursing, 2019, Volume: 49, Issue:8

    Topics: Aminoquinolines; Antibodies, Monoclonal, Humanized; Benzamides; Cannabidiol; Carbamates; Dibenzothiepins; Drug Approval; Humans; Morpholines; Oxazines; Pyridines; Pyridones; Thiepins; Triazines; United States; United States Food and Drug Administration

2019
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
    Neuropharmacology, 2020, Volume: 163

    Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecoxib; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Oxidopamine; Pain; Parkinson Disease; Piperidines; Pyrazoles; Thienamycins

2020
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
    European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cannabidiol; Carbamates; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Structure-Activity Relationship

2021